IL17A and myasthenia gravis: One of the most explored is the role of IL-17 in MG pathogenesis, especially in EOMG, where higher levels of circulating Th1/17 cells associated with a pathogenic pro-inflammatory molecular profile have been found and correlated with disease severity [95].